Medulloblastoma molecular dissection: the way toward targeted therapy

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Current Opinion in Oncology

• Publication date

  2013-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1097/CCO.0000000000000008PMID 24076581
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• DNA methylation profiling of medulloblastoma allows robust subclassification and improved outcome prediction using formalin-fixed biopsies

  2013cited by this paper
• Targeting MYCN in neuroblastoma by BET bromodomain inhibition.

  2013cited by this paper
• Robust molecular subgrouping and copy-number profiling of medulloblastoma from small amounts of archival tumour material using high-density DNA methylation arrays

  2013cited by this paper
• Aberrant patterns of H3K4 and H3K27 histone lysine methylation occur across subgroups in medulloblastoma

  2013cited by this paper
• Itraconazole and arsenic trioxide inhibit Hedgehog pathway activation and tumor growth associated with acquired resistance to smoothened antagonists.

  2013cited by this paper
• Subgroup-specific prognostic implications of TP53 mutation in medulloblastoma.

  2013cited by this paper
• Outcome of children with metastatic medulloblastoma treated with carboplatin during craniospinal radiotherapy: a Children's Oncology Group Phase I/II study.

  2012cited by this paper
• Medulloblastomics: the end of the beginning

  2012cited by this paper
• Dissecting the genomic complexity underlying medulloblastoma

  2012cited by this paper
• OTX2 sustains a bivalent-like state of OTX2-bound promoters in medulloblastoma by maintaining their H3K27me3 levels

  2012influential reference
• Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomas

  2012cited by this paper
• Clonal Selection Drives Genetic Divergence of Metastatic Medulloblastoma

  2012cited by this paper
• Distinct neural stem cell populations give rise to disparate brain tumors in response to N-MYC.

  2012cited by this paper
• Novel mutations target distinct subgroups of medulloblastoma

  2012cited by this paper
• An animal model of MYC-driven medulloblastoma.

  2012cited by this paper
• A mouse model of the most aggressive subgroup of human medulloblastoma.

  2012cited by this paper
• Subgroup-specific structural variation across 1,000 medulloblastoma genomes

  2012cited by this paper
• MEDULLOBLASTOMA EXOME SEQUENCING UNCOVERS SUBTYPE-SPECIFIC SOMATIC MUTATIONS

  2012cited by this paper
• Medulloblastoma comprises four distinct molecular variants.

  2011cited by this paper
• The Genetic Landscape of the Childhood Cancer Medulloblastoma

  2011cited by this paper
• Small molecule inhibition of GDC-0449 refractory smoothened mutants and downstream mechanisms of drug resistance.

  2011cited by this paper
• FSTL5 is a marker of poor prognosis in non-WNT/non-SHH medulloblastoma.

  2011cited by this paper
• Definition of disease-risk stratification groups in childhood medulloblastoma using combined clinical, pathologic, and molecular variables.

  2011cited by this paper
• Molecular subgroups of medulloblastoma: the current consensus

  2011cited by this paper
• Mouse models of medulloblastoma

  2011cited by this paper
• Rapid, reliable, and reproducible molecular sub-grouping of clinical medulloblastoma samples

  2011cited by this paper
• Adult medulloblastoma comprises three major molecular variants.

  2011cited by this paper
• BET bromodomain inhibition as a therapeutic strategy to target c-Myc.

  2011cited by this paper
• Medulloblastoma: clinicopathological correlates of SHH, WNT, and non-SHH/WNT molecular subgroups

  2011cited by this paper
• Recent advances in the therapeutic perspectives of Nutlin-3.

  2011cited by this paper
• Integrative genomic analysis of medulloblastoma identifies a molecular subgroup that drives poor clinical outcome.

  2011cited by this paper
• FISH and chips: the recipe for improved prognostication and outcomes for children with medulloblastoma.

  2011cited by this paper
• Interfering with Resistance to Smoothened Antagonists by Inhibition of the PI3K Pathway in Medulloblastoma

  2010cited by this paper
• Subtypes of medulloblastoma have distinct developmental origins

  2010cited by this paper
• Small-molecule inhibition of Wnt signaling through activation of casein kinase 1α.

  2010cited by this paper
• Targeting c-Myc as a novel approach for hepatocellular carcinoma.

  2010cited by this paper
• Multiple recurrent genetic events converge on control of histone lysine methylation in medulloblastoma

  2009cited by this paper
• Treatment of medulloblastoma with hedgehog pathway inhibitor GDC-0449.

  2009cited by this paper
• Smoothened Mutation Confers Resistance to a Hedgehog Pathway Inhibitor in Medulloblastoma

  2009cited by this paper
• Genomics identifies medulloblastoma subgroups that are enriched for specific genetic alterations.

  2006cited by this paper
• Wnt/Wingless Pathway Activation and Chromosome 6 Loss Characterise a Distinct Molecular Sub-Group of Medulloblastomas Associated with a Favourable Prognosis

  2006cited by this paper
• Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma.

  2006cited by this paper
• Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trial.

  2006cited by this paper
• Multiagent chemotherapy and deferred radiotherapy in infants with malignant brain tumors: a report from the Children's Cancer Group.

  2005cited by this paper
• Treatment of early childhood medulloblastoma by postoperative chemotherapy alone.

  2005cited by this paper
• beta-Catenin status predicts a favorable outcome in childhood medulloblastoma: the United Kingdom Children's Cancer Study Group Brain Tumour Committee.

  2005cited by this paper
• Neurocognitive consequences of risk-adapted therapy for childhood medulloblastoma.

  2005cited by this paper
• An essential role for CoREST in nucleosomal histone 3 lysine 4 demethylation

  2005cited by this paper
• Mutations in SUFU predispose to medulloblastoma

  2002influential reference
• Altered neural cell fates and medulloblastoma in mouse patched mutants.

  1997cited by this paper
• Mutations of the human homolog of Drosophila patched in the nevoid basal cell carcinoma syndrome.

  1996cited by this paper

• Medulloblastoma in Adolescents and Young Adults (AYA): Bridging Pediatric Paradigms and Adult Oncology Practice

  2025cites this paper
• Human stem cell models to unravel brain cancer

  2024cites this paper
• Combination of PARP and WEE1 inhibitors in vitro: Potential for use in the treatment of SHH medulloblastoma

  2023cites this paper
• Spatial transcriptomic analysis of Sonic Hedgehog Medulloblastoma identifies that the loss of heterogeneity and promotion of differentiation underlies the response to CDK4/6 inhibition

  2023cites this paper
• Spatial transcriptomic analysis of Sonic hedgehog medulloblastoma identifies that the loss of heterogeneity and promotion of differentiation underlies the response to CDK4/6 inhibition

  2023cites this paper
• The long non-coding RNA OTX2-AS1 promotes tumor growth and predicts response to BCL-2 inhibition in medulloblastoma

  2023cites this paper
• KMT2D suppresses Sonic hedgehog-driven medulloblastoma progression and metastasis

  2023cites this paper
• hGFAP-mediated GLI2 overexpression leads to early death and severe cerebellar malformations with rare tumor formation

  2023cites this paper
• Adult Medulloblastoma: Updates on Current Management and Future Perspectives

  2022cites this paper
• NRP1 inhibition modulates radiosensitivity of medulloblastoma by targeting cancer stem cells

  2022cites this paper
• Protocols to Manufacture an Oncolytic Measles Virus-Sensitive Immunocompetent Mouse Model of Medulloblastoma.

  2022cites this paper
• Molecular Targeted Therapies: Time for a Paradigm Shift in Medulloblastoma Treatment?

  2022cites this paper
• Individualized discovery of rare cancer drivers in global network context

  2021cites this paper
• MicroRNAs as Biomarkers and Therapeutic Targets for Medulloblastomas

  2021cites this paper
• Микро-РНК как биомаркеры и терапевтические мишени при медуллобластомах

  2021cites this paper
• Systems pharmacogenomics identifies novel targets and clinically actionable therapeutics for medulloblastoma

  2021cites this paper
• Reliable tumor detection by whole-genome methylation sequencing of cell-free DNA in cerebrospinal fluid of pediatric medulloblastoma

  2020cites this paper
• Evaluation of Protein Kinase Inhibitors with PLK4 Cross-Over Potential in a Pre-Clinical Model of Cancer

  2019cites this paper
• Phase I and phase II sonidegib and vismodegib clinical trials for the treatment of paediatric and adult MB patients: a systemic review and meta-analysis

  2019cites this paper
• Childhood medulloblastoma—a single institution’s historical perspective on survival and functional morbidity

  2019cites this paper
• Subgroup-specific prognostic signaling and metabolic pathways in pediatric medulloblastoma

  2019cites this paper
• The long noncoding RNA TP73‐AS1 promotes tumorigenicity of medulloblastoma cells

  2019cites this paper
• Medulloblastoma

  2019cites this paper
• Differential patterns of metastatic dissemination across medulloblastoma subgroups.

  2018cites this paper
• Imaging Features of Common Pediatric Intracranial Tumours: A Primer for the Radiology Trainee

  2018cites this paper
• Advances in Genomics Explain Medulloblastoma Behavior at the Bedside.

  2017cites this paper
• Molecular Biology of Human Brain Tumors

  2017cites this paper
• Intra-Cavity Stem Cells Target Post-Surgical Brain Tumor Progression In Novel Resection And Recurrence Mouse Models

  2017cites this paper
• Survival in pediatric medulloblastoma: a population-based observational study to improve prognostication

  2017cites this paper
• Brain Cancer Stem Cells in Adults and Children: Cell Biology and Therapeutic Implications

  2017cites this paper
• Inhibition of WNT signaling attenuates self-renewal of SHH-subgroup medulloblastoma

  2017cites this paper
• Erratum to: The DNA methyltransferase inhibitor zebularine exerts antitumor effects and reveals BATF2 as a poor prognostic marker for childhood medulloblastoma

  2017cites this paper
• Polo-Like Kinase 1 Pharmacological Inhibition as Monotherapy or in Combination: Comparative Effects of Polo-Like Kinase 1 Inhibition in Medulloblastoma Cells.

  2017cites this paper
• Spatial heterogeneity in medulloblastoma

  2017cites this paper
• PLK1-associated microRNAs are correlated with pediatric medulloblastoma prognosis

  2017cites this paper
• Establishment of a novel human medulloblastoma cell line characterized by highly aggressive stem-like cells

  2016cites this paper
• Non-invasive metabolic imaging of brain tumours in the era of precision medicine

  2016cites this paper
• The DNA methyltransferase inhibitor zebularine exerts antitumor effects and reveals BATF2 as a poor prognostic marker for childhood medulloblastoma

  2016cites this paper
• The Calcium-Sensing Receptor and Integrins in Cellular Differentiation and Migration

  2016cites this paper
• Evolving molecular era of childhood medulloblastoma: time to revisit therapy.

  2016cites this paper
• Intellectual Outcome in Molecular Subgroups of Medulloblastoma.

  2016cites this paper
• Insights into cerebellar development and medulloblastoma.

  2016cites this paper
• Common Pediatric Central Nervous System Tumors: Histology and Molecular Biology

  2016cites this paper
• Sortilin is a Negative Regulator of Sonic Hedgehog Processing and Anterograde Trafficking in Neurons

  2016cites this paper
• Genetic Predictors of intellectual and white matter outcome in pediatric brain tumor patients

  2015influential citation
• REST REGULATORY CIRCUIT CONTROLS DISTINCT ONCOGENIC PROPERTIES OF GLIOBLASTOMA STEM CELLS THROUGH SPECIFIC MICRORNAs

  2015cites this paper
• Contemporary murine models in preclinical astrocytoma drug development.

  2015cites this paper
• The Antiproliferative and Pro-apoptotic Effects of Methoxyamine on Pediatric Medulloblastoma Cell Lines Exposed to Ionizing Radiation and Chemotherapy.

  2015cites this paper
• SHH inhibitors for the treatment of medulloblastoma

  2015cites this paper
• Wnt pathway in atypical teratoid rhabdoid tumors.

  2015cites this paper
• Clinical implications of medulloblastoma subgroups: incidence of CSF diversion surgery.

  2015cites this paper
• Coagulation and angiogenic gene expression profiles are defined by molecular subgroups of medulloblastoma: evidence for growth factor‐thrombin cross‐talk

  2014cites this paper
• MicroRNA Signatures as Biomarkers and Therapeutic Target for CNS Embryonal Tumors: The Pros and the Cons

  2014cites this paper
• Multiple spinal osteochondromata and osteosarcoma in a patient with Gorlin's syndrome.

  2014cites this paper
• Treatment developments and the unfolding of the quality of life discussion in childhood medulloblastoma: a review

  2014cites this paper
• It takes two to tango, a dance between the cells of origin and cancer stem cells in the Drosophila larval brain.

  2014cites this paper
• Large cell anaplastic medulloblastoma metastatic to the scalp: tumor and derived stem-like cells features

  2014cites this paper
• Roles for Hedgehog signaling in adult organ homeostasis and repair

  2014cites this paper
• In Vivo Mn-Enhanced MRI for Early Tumor Detection and Growth Rate Analysis in a Mouse Medulloblastoma Model12

  2014cites this paper
• Calcium-sensing Receptor and Integrin Protein Complexes in Cerebellar Development and Cancer Cell Migration

  2014cites this paper
• WITHAFERIN A: A NOVEL THERAPEUTIC APPROACH FOR MALIGANT BRAIN TUMORS

  2014cites this paper
• Investigating the role of Dachshund Homolog 1 (DACH1) and miR-200b in Group 4 medulloblastoma pathogenesis

  2014cites this paper
• Clinical implications of medulloblastoma subgroups: incidence of CSF diversion surgery

  2014cites this paper
• The UCSC Cancer Genomics Browser: update 2015

  2014cites this paper